Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

December 31, 2025

Conditions

Yellow FeverImmunization; Infection

Interventions

BIOLOGICAL

17D

Vaccine administration in subjects previously vaccinated with 17D.

Trial Locations (1)

RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER